Chemical speciation of arsenic in serum of uraemic patients

被引:26
作者
Zhang, XR
Cornelis, R
Mees, L
Vanholder, R
Lameire, N
机构
[1] State Univ Ghent, Inst Nucl Sci, Analyt Chem Lab, B-9000 Ghent, Belgium
[2] State Univ Ghent Hosp, Dept Med, Div Renal, B-9000 Ghent, Belgium
关键词
speciation; serum arsenic; uraemic patients; dialysis; liquid chromatography; hydride generation atomic absorption spectrometry;
D O I
10.1039/a704841f
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Chemical speciation of arsenic was carried out in serum of a total of 51 uraemic patients: 19 non dialysis (ND), 18 haemodialysis (HD) and 14 continuous ambulatory peritoneal dialysis (CAPD) patients, The low molecular mass As species were separated by ion-exchange liquid chromatography and measured on-line by hydride generation atomic absorption spectrometry (HGAAS), The high molecular mass As species were separated by fast protein liquid chromatography, either size-exclusion, ion-exchange or affinity chromatography; and the fractions were digested and measured off-line with HGAAS. The mean total As concentrations in the serum of the three groups of the uraemic patients were significantly higher than the reference value (6.47 +/- 4.28, 5.12 +/- 5.58 and 4.67 +/- 5.41 mu g l(-1) for HD, ND and CAPD patients, respectively, versus the reference value of 0.96 +/- 1.52 mu g l(-1)), The major As species in serum of the patients were dimethylarsinic acid (DMA) and arsenobetaine, The HD patients showed a significantly higher mean DMA level than ND and CAPD patients, No selective removal of different As species in serum of HD patients was observed after 4 h of haemodialysis, The inorganic As species in serum were bound to proteins, mainly transferrin (about 5-6% of total As in serum), This binding may play an important role in arsenic detoxification.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 18 条
[1]  
ALVADEO A, 1977, INT J ARTIF ORGANS, V2, P17
[2]  
ASTRUG A, 1984, TRACE ELEM MED, V1, P65
[3]   A COMPARISON BETWEEN AMOUNTS OF AS AU BR CU FE MO SE AND ZN IN NORMAL AND URAEMIC HUMAN WHOLE BLOOD BY MEANS OF NEUTRON ACTIVATION ANALYSIS [J].
BRUNE, D ;
SAMSAHL, K ;
WESTER, PO .
CLINICA CHIMICA ACTA, 1966, 13 (03) :285-&
[4]   MORE THAN TENFOLD INCREASE OF ARSENIC IN SERUM AND PACKED CELLS OF CHRONIC-HEMODIALYSIS PATIENTS [J].
DEKIMPE, J ;
CORNELIS, R ;
MEES, L ;
VANLIERDE, S ;
VANHOLDER, R .
AMERICAN JOURNAL OF NEPHROLOGY, 1993, 13 (06) :429-434
[5]  
Malvano R., 1967, NUCLEAR ACTIVATION T, P511
[6]  
Shiomi Kazuo, 1994, V27, P261
[7]   A CHEMICAL HYPOTHESIS FOR ARSENIC METHYLATION IN MAMMALS [J].
THOMPSON, DJ .
CHEMICO-BIOLOGICAL INTERACTIONS, 1993, 88 (2-3) :89-114
[8]   INVIVO REDUCTION OF ARSENATE IN MICE AND RABBITS [J].
VAHTER, M ;
ENVALL, J .
ENVIRONMENTAL RESEARCH, 1983, 32 (01) :14-24
[9]  
VAHTER M, 1988, SPECIAL PUBLICATION, V66, P105
[10]  
VAHTER ME, 1988, BIOL MONITORING TOXI, P303